Bionano Genomics Files Definitive Proxy Statement
Ticker: BNGO · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 1411690
| Field | Detail |
|---|---|
| Company | Bionano Genomics, Inc. (BNGO) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, annual-meeting
Related Tickers: BNGO
TL;DR
Bionano Genomics (BNGO) proxy statement filed, shareholders vote June 11.
AI Summary
Bionano Genomics, Inc. filed its definitive proxy statement on April 28, 2025, for its annual meeting on June 11, 2025. The filing, under SEC Act of 1934, concerns the election of directors and other corporate matters. The company, headquartered in San Diego, CA, operates in the laboratory analytical instruments sector.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance and upcoming voting matters, impacting their ability to make informed decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial or operational information.
Key Numbers
- 1934 Act — SEC Act (Governing legislation for the filing)
Key Players & Entities
- Bionano Genomics, Inc. (company) — Registrant
- 0001140361-25-016025 (filing_id) — Accession Number
- 20250428 (date) — Filing Date
- 20250611 (date) — Meeting Date
- San Diego, CA (location) — Company Headquarters
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing is a definitive proxy statement filed with the SEC, providing shareholders with information about matters to be voted on at an upcoming shareholder meeting, such as the election of directors.
When is the Bionano Genomics annual meeting scheduled?
The annual meeting is scheduled for June 11, 2025.
What is Bionano Genomics' primary business sector?
Bionano Genomics operates in the Laboratory Analytical Instruments sector, with SIC code 3826.
Where is Bionano Genomics headquartered?
Bionano Genomics is headquartered at 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121.
What is the filing date of this proxy statement?
The definitive proxy statement was filed on April 28, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Bionano Genomics, Inc. (BNGO).